Does the ALBI score reflect early right ventricular dysfunction in a stable pediatric cohort after repair of Tetralogy of Fallot?
The ALBI score does not appear to be a useful biomarker for detecting early, subclinical right ventricular dysfunction in stable pediatric patients following Tetralogy of Fallot repair.
Despite structural and biomarker evidence of subclinical RV involvement, the ALBI score did not reflect early right ventricular dysfunction in this relatively stable pediatric TOF cohort. Prospective studies including patients with more advanced hemodynamic impairment are warranted to clarify whether ALBI may have prognostic or monitoring value in later stages of right ventricular dysfunction.
Sönmez et al. (Wed,) studied this question.